Details

Circular RNA in hepatocellular carcinoma : emerging therapeutic strategies
ID Jazbec, Gregor (Author), ID Režen, Tadeja (Author)

.pdfPDF - Presentation file, Download (2,29 MB)
MD5: C1AD91F38CCF8CED361B2626B024B656
URLURL - Source URL, Visit https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2025.1722576/full This link opens in a new window

Abstract
Circular RNAs, or circRNAs, are unique single-stranded RNA molecules that form covalently closed circles. They possess a wide range of cellular functions and can act as tumor suppressors or promoters, regulating various aspects of carcinogenesis. These functions include acting as microRNA sponges, nteracting with and binding to proteins and mRNA, regulating transcription and RNA splicing, translating into proteins, and serving as cargo in exosomes. Due to their diverse cellular roles and enhanced molecular stability, circRNAs are not only promising biomarkers but also emerging candidates for the development of RNA-based therapeutics. In this review, we explored the therapeutic potential of circular RNA by reviewing the current state of the art n the field of oncology, with a particular focus on hepatocellular carcinoma. Based on their endogenous functions, circular RNA can be designed, synthesized and delivered to produce various proteins, such as neoantigens and cytokines, or to sequester oncogenic microRNA in tumor cells. Although many therapeutic applications of circular RNA are still in the early stages of development, they have already shown promising results in both in vitro and in vivo animal models. In summary, circular RNAs are emerging as both therapeutics and biomarkers in iver cancer and broader oncology, with relevant clinical applicability, particularly n immunotherapy.

Language:English
Keywords:RNA-based therapeutics, circRNA, circRNA-based therapeutics, hepatocellular carcinoma, immunotherapy
Work type:Article
Typology:1.02 - Review Article
Organization:MF - Faculty of Medicine
Publication status:Published
Publication version:Version of Record
Submitted for review:20.11.2025
Article acceptance date:25.11.2025
Publication date:09.12.2025
Year:2025
Number of pages:16 str.
Numbering:Vol. 16, art. 1722576
PID:20.500.12556/RUL-177805 This link opens in a new window
UDC:577.2
ISSN on article:1664-3224
DOI:10.3389/fimmu.2025.1722576 This link opens in a new window
COBISS.SI-ID:263803139 This link opens in a new window
Publication date in RUL:08.01.2026
Views:429
Downloads:222
Metadata:XML DC-XML DC-RDF
:
Copy citation
Share:Bookmark and Share

Record is a part of a journal

Title:Frontiers in immunology
Shortened title:Front. immunol.
Publisher:Frontiers Media
ISSN:1664-3224
COBISS.SI-ID:30774233 This link opens in a new window

Licences

License:CC BY 4.0, Creative Commons Attribution 4.0 International
Link:http://creativecommons.org/licenses/by/4.0/
Description:This is the standard Creative Commons license that gives others maximum freedom to do what they want with the work as long as they credit the author.

Secondary language

Language:Slovenian
Keywords:terapija na osnovi RNA, cirkularna RNA, terapija na osnovi cirkularne RNA, hepatocelularni karcinom, imunoterapija

Projects

Funder:ARIS - Slovenian Research and Innovation Agency
Project number:P1-0390
Name:Funkcijska genomika in biotehnologija za zdravje

Funder:ARIS - Slovenian Research and Innovation Agency
Project number:I0-0022
Name:Mreža raziskovalnih infrastrukturnih centrov Univerze v Ljubljani (MRIC UL)

Funder:ARIS - Slovenian Research and Innovation Agency
Project number:J3-4513
Name:Vloga in aplikativnost krožnih RNA pri raku jeter

Funder:ARIS - Slovenian Research and Innovation Agency
Funding programme:Young researchers

Similar documents

Similar works from RUL:
Similar works from other Slovenian collections:

Back